Ontology highlight
ABSTRACT:
SUBMITTER: Vairy S
PROVIDER: S-EPMC6237143 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
Vairy Stephanie S Garcia Julia Lopes JL Teira Pierre P Bittencourt Henrique H
Drug design, development and therapy 20181112
Over the past decades, survival of patients with acute lymphoblastic leukemia (ALL) has dramatically improved, but the subgroup of patients with relapsed/refractory ALL still continues to have dismal prognosis. As an emerging therapeutic approach, chimeric antigen receptor-modified T-cells (CAR-T) represent one of the few practice-changing therapies for this subgroup of patients. Originally conceived and built in Philadelphia (University of Pennsylvania), CTL019 or tisagenlecleucel, the first CA ...[more]